Latest pharma updates on New Developments

Weekly Pharma Update: NEXPLANON Extension & Biosimilars

FDA Approves Extended-Use NEXPLANON® Implant What’s new: The U.S. Food and Drug Administration (FDA) approv...

Read Full Story

Weekly Pharma Update – 15th to 27th December 2025

1) FDA Approves Lunsumio VELO™ for Subcutaneous Use in Follicular Lymphoma Date: 22 December 2025 What’s...

Read Full Story